Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

April 21, 2017

Study Completion Date

May 5, 2017

Conditions
Insomnia Disorder
Interventions
DRUG

Zolpidem

Commercially available tablets of zolpidem (5 or 10 mg) for oral use

Trial Locations (9)

10019

Clinilabs NYC, New York

10115

St-Hedwig Krankenhaus, Schlaflab, Berlin

10117

Advanced Sleep Research Berlin, Berlin

19053

Somnibene Inst Med Forschung & Schlafmedizin, Schwerin

20251

CTC North, Universitätsklinikum Hamburg- Eppendorf, Hamburg

30342

Neurotrials Research Inc, Atlanta

45255

CTI Clinical Research Center, Cincinnati

89104

Clinical Research CTR of Nevada, Las Vegas

90404

Santa Monica Clinical Trials, Santa Monica

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY